WO2005087310A3 - Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar - Google Patents

Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar Download PDF

Info

Publication number
WO2005087310A3
WO2005087310A3 PCT/IL2005/000316 IL2005000316W WO2005087310A3 WO 2005087310 A3 WO2005087310 A3 WO 2005087310A3 IL 2005000316 W IL2005000316 W IL 2005000316W WO 2005087310 A3 WO2005087310 A3 WO 2005087310A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood sugar
treating disorders
controlling blood
gastrointestinal methods
pancreas
Prior art date
Application number
PCT/IL2005/000316
Other languages
French (fr)
Other versions
WO2005087310A2 (en
Inventor
Tami Harel
Yuval Mika
Original Assignee
Metacure Nv
Tami Harel
Yuval Mika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/804,560 external-priority patent/US20040249421A1/en
Priority claimed from PCT/IL2004/000551 external-priority patent/WO2004112883A2/en
Priority claimed from PCT/IL2004/000550 external-priority patent/WO2004112563A2/en
Priority claimed from PCT/IL2004/000664 external-priority patent/WO2005007232A2/en
Priority to US10/599,015 priority Critical patent/US8666495B2/en
Priority to EP05718889A priority patent/EP1735047A4/en
Application filed by Metacure Nv, Tami Harel, Yuval Mika filed Critical Metacure Nv
Publication of WO2005087310A2 publication Critical patent/WO2005087310A2/en
Publication of WO2005087310A3 publication Critical patent/WO2005087310A3/en
Priority to EP05853465.2A priority patent/EP1827571B1/en
Priority to US11/792,811 priority patent/US9931503B2/en
Priority to CA002594673A priority patent/CA2594673A1/en
Priority to PCT/US2005/044557 priority patent/WO2006073671A1/en
Priority to PCT/IL2006/000204 priority patent/WO2006087717A2/en
Priority to EP06711186.4A priority patent/EP1868679B1/en
Priority to US11/884,389 priority patent/US9101765B2/en
Priority to PCT/IL2006/000345 priority patent/WO2006097934A2/en
Priority to US11/886,154 priority patent/US8244371B2/en
Priority to US14/821,848 priority patent/US9821158B2/en
Priority to US15/942,637 priority patent/US11439815B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
    • A61B5/4222—Evaluating particular parts, e.g. particular organs
    • A61B5/425—Evaluating particular parts, e.g. particular organs pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Abstract

A method of glucose level control comprising providing at least one electrode adapted to apply an electric field to a pancreas; and applying an electric field to the pancreas using said at least one electrode such that blood glucose levels are significantly reduced and blood insulin levels are not significantly increased compared to a regular insulin response in a same person. 2
PCT/IL2005/000316 1999-03-05 2005-03-18 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar WO2005087310A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US10/599,015 US8666495B2 (en) 1999-03-05 2005-03-18 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
EP05718889A EP1735047A4 (en) 2004-03-18 2005-03-18 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
PCT/US2005/044557 WO2006073671A1 (en) 2004-12-09 2005-12-09 Protein activity modification
CA002594673A CA2594673A1 (en) 2004-12-09 2005-12-09 Protein activity modification
EP05853465.2A EP1827571B1 (en) 2004-12-09 2005-12-09 Protein activity modification
US11/792,811 US9931503B2 (en) 2003-03-10 2005-12-09 Protein activity modification
US11/884,389 US9101765B2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy
EP06711186.4A EP1868679B1 (en) 2005-02-17 2006-02-16 Non-immediate effects of therapy
PCT/IL2006/000204 WO2006087717A2 (en) 2005-02-17 2006-02-16 Non-immediate effects of therapy
PCT/IL2006/000345 WO2006097934A2 (en) 2005-03-18 2006-03-16 Pancreas lead
US11/886,154 US8244371B2 (en) 2005-03-18 2006-03-16 Pancreas lead
US14/821,848 US9821158B2 (en) 2005-02-17 2015-08-10 Non-immediate effects of therapy
US15/942,637 US11439815B2 (en) 2003-03-10 2018-04-02 Protein activity modification

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US10/804,560 US20040249421A1 (en) 2000-09-13 2004-03-18 Blood glucose level control
US10/804,560 2004-03-18
PCT/IL2004/000550 WO2004112563A2 (en) 2003-06-20 2004-06-20 Gastrointestinal methods and apparatus for use in treating disorders
ILPCT/IL2004/000550 2004-06-20
ILPCT/IL2004/000551 2004-06-20
PCT/IL2004/000551 WO2004112883A2 (en) 2003-06-20 2004-06-20 Hepatic device for treatment or glucose detection
PCT/IL2004/000664 WO2005007232A2 (en) 2003-07-21 2004-07-21 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
ILPCT/IL2004/000664 2004-07-21
US60255004P 2004-08-18 2004-08-18
US60/602,550 2004-08-18
ILPCT/IL2004/000797 2004-09-05
PCT/IL2004/000797 WO2005023081A2 (en) 2003-09-04 2004-09-05 Blood glucose level control
US65405605P 2005-02-17 2005-02-17
US60/654,056 2005-02-17

Related Parent Applications (5)

Application Number Title Priority Date Filing Date
US10/804,560 Continuation-In-Part US20040249421A1 (en) 1999-03-05 2004-03-18 Blood glucose level control
PCT/IL2004/000550 Continuation-In-Part WO2004112563A2 (en) 1999-03-05 2004-06-20 Gastrointestinal methods and apparatus for use in treating disorders
PCT/IL2004/000664 Continuation-In-Part WO2005007232A2 (en) 2003-03-10 2004-07-21 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
PCT/IL2004/000797 Continuation-In-Part WO2005023081A2 (en) 1999-03-05 2004-09-05 Blood glucose level control
PCT/US2005/044557 Continuation-In-Part WO2006073671A1 (en) 1999-03-05 2005-12-09 Protein activity modification

Related Child Applications (7)

Application Number Title Priority Date Filing Date
US10/526,708 Continuation-In-Part US8700161B2 (en) 1999-03-05 2003-09-04 Blood glucose level control
PCT/IL2003/000736 Continuation-In-Part WO2004021858A2 (en) 1999-03-05 2003-09-04 Blood glucose level control
PCT/US2005/044557 Continuation-In-Part WO2006073671A1 (en) 1999-03-05 2005-12-09 Protein activity modification
US11/792,811 Continuation-In-Part US9931503B2 (en) 2003-03-10 2005-12-09 Protein activity modification
US11/884,389 Continuation-In-Part US9101765B2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy
PCT/IL2006/000204 Continuation-In-Part WO2006087717A2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy
US11/886,154 Continuation-In-Part US8244371B2 (en) 2005-03-18 2006-03-16 Pancreas lead

Publications (2)

Publication Number Publication Date
WO2005087310A2 WO2005087310A2 (en) 2005-09-22
WO2005087310A3 true WO2005087310A3 (en) 2005-10-20

Family

ID=56290675

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2005/000316 WO2005087310A2 (en) 1999-03-05 2005-03-18 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar

Country Status (2)

Country Link
EP (1) EP1735047A4 (en)
WO (1) WO2005087310A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8442841B2 (en) 2005-10-20 2013-05-14 Matacure N.V. Patient selection method for assisting weight loss
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US8958872B2 (en) 1996-01-08 2015-02-17 Impulse Dynamics, N.V. Electrical muscle controller
US8977353B2 (en) 2004-03-10 2015-03-10 Impulse Dynamics Nv Protein activity modification
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US9265930B2 (en) 1997-07-16 2016-02-23 Metacure Limited Methods and devices for modifying vascular parameters
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US9931503B2 (en) 2003-03-10 2018-04-03 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
WO2006102626A2 (en) 2005-03-24 2006-09-28 Metacure Nv Wireless leads for gastrointestinal tract applications
US20070016262A1 (en) 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US9233075B2 (en) 2005-08-09 2016-01-12 Metacure Limited Satiety
US8417329B2 (en) 2007-05-09 2013-04-09 Metacure Ltd. Analysis and regulation of food intake
US7634315B2 (en) 2007-05-31 2009-12-15 Pacesetter, Inc. Techniques to monitor and trend nerve damage and recovery
US9486623B2 (en) 2014-03-05 2016-11-08 Rainbow Medical Ltd. Electrical stimulation of a pancreas

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6684104B2 (en) * 1999-04-14 2004-01-27 Transneuronix, Inc. Gastric stimulator apparatus and method for installing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6243607B1 (en) * 1996-09-05 2001-06-05 University Technologies International Inc. Gastro-intestinal electrical pacemaker
EP1159030B1 (en) * 1999-03-05 2007-06-13 Impulse Dynamics N.V. Blood glucose level control
US7437195B2 (en) * 2001-01-05 2008-10-14 Metalure N.V. Regulation of eating habits

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6684104B2 (en) * 1999-04-14 2004-01-27 Transneuronix, Inc. Gastric stimulator apparatus and method for installing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1735047A4 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8958872B2 (en) 1996-01-08 2015-02-17 Impulse Dynamics, N.V. Electrical muscle controller
US9186514B2 (en) 1996-01-08 2015-11-17 Impulse Dynamics Nv Electrical muscle controller
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9265930B2 (en) 1997-07-16 2016-02-23 Metacure Limited Methods and devices for modifying vascular parameters
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8977353B2 (en) 2004-03-10 2015-03-10 Impulse Dynamics Nv Protein activity modification
US9440080B2 (en) 2004-03-10 2016-09-13 Impulse Dynamics Nv Protein activity modification
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities
US8442841B2 (en) 2005-10-20 2013-05-14 Matacure N.V. Patient selection method for assisting weight loss
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy

Also Published As

Publication number Publication date
EP1735047A4 (en) 2011-02-09
EP1735047A2 (en) 2006-12-27
WO2005087310A2 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
WO2005087310A3 (en) Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
WO2005023081A3 (en) Blood glucose level control
WO2004021858A3 (en) Blood glucose level control
WO2004103455A3 (en) Selective nerve fiber stimulation for heart treatment
WO2005007232A3 (en) Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
WO2006073484A3 (en) Treating inflammatory disorders by electrical vagus nerve stimulation
WO2005091933A3 (en) Skin treatment method with lactobacillus extract
WO2009016634A3 (en) Method and device for collagen growth stimulation
AU2003239474A1 (en) Device and method for the treatment of cardiac disorders
WO2007041300A3 (en) Iontophoresis method and apparatus for systemic delivery of active agents
WO2005002664A3 (en) Methods and apparatus for effectuating a lasting change in a neural-function of a patient
WO2004082528A3 (en) Vascular valve with removable support component
GB2455364B (en) Electrotherapy wound treatment device
WO2001082771A3 (en) Signal delivery through the right ventricular septum
WO2003080545A3 (en) Substituted phenylacetic acids
WO2007048087A3 (en) System and method for controlling hypothalamic function via vestibular stimulation
DE60121194D1 (en) SYSTEM FOR CHANGING THERAPY PARAMETERS
AU2003237776A1 (en) Method and apparatus for an extracorporeal treatment device to control blood withdrawal and infusion
WO2006138045A3 (en) System for patient specific spinal therapy
WO2010044879A3 (en) Method and devices for self adjusting phototherapeutic intervention
WO2006099413A3 (en) Devices, methods and kits for radiation treatment via a target body surface
WO2008061150A3 (en) Methods and apparatus for intravascularly-induced neuromodulation or denervation
WO2006041664A3 (en) Baroreflex activation and cardiac resynchronization for heart failure treatment
WO2003082403A3 (en) Devices and methods for cardiovascular reflex control via coupled electrodes
WO2005094260A3 (en) Microsurgical tissue treatment system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005718889

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005718889

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10599015

Country of ref document: US